IL136342A0 - Formulation for topical treatment of skin infections - Google Patents

Formulation for topical treatment of skin infections

Info

Publication number
IL136342A0
IL136342A0 IL13634298A IL13634298A IL136342A0 IL 136342 A0 IL136342 A0 IL 136342A0 IL 13634298 A IL13634298 A IL 13634298A IL 13634298 A IL13634298 A IL 13634298A IL 136342 A0 IL136342 A0 IL 136342A0
Authority
IL
Israel
Prior art keywords
formulation
topical treatment
skin infections
infections
skin
Prior art date
Application number
IL13634298A
Original Assignee
Yissum Res Dev Co
Hadasit Med Res Service
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co, Hadasit Med Res Service filed Critical Yissum Res Dev Co
Publication of IL136342A0 publication Critical patent/IL136342A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL13634298A 1997-12-01 1998-11-30 Formulation for topical treatment of skin infections IL136342A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6748597P 1997-12-01 1997-12-01
US10178398P 1998-09-25 1998-09-25
PCT/IL1998/000582 WO1999027940A1 (en) 1997-12-01 1998-11-30 Formulations for topical treatment of skin infections

Publications (1)

Publication Number Publication Date
IL136342A0 true IL136342A0 (en) 2001-05-20

Family

ID=26747915

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13634298A IL136342A0 (en) 1997-12-01 1998-11-30 Formulation for topical treatment of skin infections

Country Status (3)

Country Link
AU (1) AU1350099A (en)
IL (1) IL136342A0 (en)
WO (1) WO1999027940A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307079D0 (en) * 2003-03-27 2003-04-30 Stone Island Holdings Ltd Allicin
AU2004233873B2 (en) 2003-04-25 2010-11-18 The Penn State Research Foundation Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
ES2387440B2 (en) * 2010-09-27 2014-02-04 Universidad Complutense De Madrid TOPIC FORMULATIONS OF ANPHOTERICINE B AND METHOD OF OBTAINING

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT78628B (en) * 1984-05-02 1986-06-18 Liposome Co Inc Pharmaceutical composition with reduced toxicity
FR2593394A1 (en) * 1986-01-30 1987-07-31 Ire Celltarg Sa Method for preparing liposomes containing a lipophilic active substance, in particular amphotericin, and liposomes and new medicament which are obtained
IE60901B1 (en) * 1986-08-21 1994-08-24 Vestar Inc Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
WO1990006775A1 (en) * 1988-12-14 1990-06-28 Liposome Technology, Inc. A novel nonphospholipid liposome composition for sustained release of drugs
US5277914A (en) * 1989-03-31 1994-01-11 The Regents Of The University Of California Preparation of liposome and lipid complex compositions
FR2651680B1 (en) * 1989-09-14 1991-12-27 Medgenix Group Sa NOVEL PROCESS FOR THE PREPARATION OF LIPID MICROPARTICLES.
JP2785981B2 (en) * 1989-11-20 1998-08-13 株式会社資生堂 Emulsion composition
DE4208527A1 (en) * 1992-03-17 1993-09-23 Max Planck Gesellschaft LIPOSOMES WITH NEGATIVE EXCESS CHARGE

Also Published As

Publication number Publication date
AU1350099A (en) 1999-06-16
WO1999027940A1 (en) 1999-06-10

Similar Documents

Publication Publication Date Title
EE04390B1 (en) Topical preparation for the treatment of dermatological conditions
ZA96740B (en) Skin treatment composition
AU3406997A (en) Topical product formulations containing strontium for reducing skin irritation
EP0815838A3 (en) External skin treatment composition
AUPQ877300A0 (en) Topical treatment of skin
AU1773600A (en) Topical treatment of skin disease
AU4774597A (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
PL336760A1 (en) Treatment of skin diseases
ID21874A (en) USE OF 1-HYDROXY-2-PYRIDON FOR TREATMENT OF SKIN INFECTION
AU2068295A (en) Skin treatment composition
PL349910A1 (en) Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
IL136342A0 (en) Formulation for topical treatment of skin infections
IL124764A0 (en) Topical composition for treatment of baldness
AU2509801A (en) Method for the cosmetic treatment of human skin
AU6720698A (en) Pharmaceutical compositions containing colostrum and the use of colostrum for the treatment of hair loss
GB9906808D0 (en) Formulation for treatment of pain
ZA97253B (en) Topical compositions for the treatment of skin diseases
AU5523298A (en) Novel topical formulation of anti-inflammatory drugs for the treatment of localized pain
IL122358A0 (en) Stable gel formulation for topical treatment of skin conditions
DE9413599U1 (en) Agent for topical skin treatment
AU5146600A (en) Topical compositions providing improved treatment of skin or scalp fungal infections
IL105296A0 (en) Pharmaceutical formulation for topical application in the treatment of dry skin
GB0028468D0 (en) Composition for topical treatment of skin
AU2001272195A1 (en) Topical treatment of skin
ZA951654B (en) Combined treatment of human retroviral infections

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees